MindShift
News on psychedelics in research, policy, business, and society, curated by a scientist and a science journalist.
Connect
Learn how a single dose of LSD provided lasting relief for patients with generalized anxiety disorder, why NFL athletes are turning to ayahuasca, and how a Trump-supporting billionaire took control of once America’s most prominent psychedelic company.
Discover how psilocybin brings images into the mind of people normally deprived of mental imagery, explore a compound that strips the mind naked down to pure awareness, and get the latest psychedelic business news, including a groundbreaking $1.2 billion acquisition.
Explore non-hallucinogenic psychedelics, find out why the former governor of Texas is championing ibogaine, and take away lessons from Switzerland, the birthplace of LSD.
Dive into the dark world of psychedelic cults, hear about psilocybin’s potential for treating alcohol use disorder, and learn how clinical trials may work without placebos.
Learn about the surprising U.S. conservative embrace of psychedelics, how psilocybin might help keep you young (with very high doses, though), and discover a long story about AI sitters.
